PepsiCo Balances Ethiopian Capacity Bet Against Softer Snack Demand

PepsiCo plans a tenfold rise in Ethiopian snack output and 500+ new jobs, while GLP-1 weight-loss drugs and European costs pressure its outlook.

PepsiCo is pressing ahead with a major capacity expansion in East Africa at the same time that shifting consumer habits at home are forcing analysts to recalibrate their expectations for the snack and beverage giant. The stock traded at EUR 115.30 in German dealings, up 0.6%, while the shares also changed hands in Europe at EUR 115.16 for a gain of 0.5%.

A Tenfold Jump in Ethiopian Snack Output

The centerpiece of the overseas push is a capital injection worth roughly two billion Ethiopian birr, earmarked for the existing Senselet facility situated about 65 kilometers from Addis Ababa. PepsiCo intends to add another production line dedicated to potato chips and snacks, a channel through which SUN Chips products are distributed. The blueprint calls for multiplying local snack output tenfold and creating more than 500 jobs on top of the plant's current workforce of over 150. Before any of that happens, the agreement still hinges on securing the necessary regulatory approvals and investment incentives.

Packaging Coalition Takes Shape

Running alongside the regional build-out is a separate effort to rethink how the company packages its goods. PepsiCo has joined a coalition convened by the Ellen MacArthur Foundation that counts Nestlé, Unilever and Procter & Gamble among its members. The group is working to develop paper-based, recyclable substitutes for flexible plastic packaging, testing biodegradable coatings designed to preserve product protection and shelf life. Markets with heavy plastic usage and no functioning collection or recycling infrastructure are the primary target.

European Operations Under Strain

Growth ambitions in East Africa stand in contrast to a tougher operating picture in parts of Europe. Higher distribution expenses and extraordinary supplier fees weighed on the results of the Greek unit in particular. Management in the region is bracing for continued pressure from raw material, energy and transportation costs through the current year.

GLP-1 Drugs Reshape the Snack Aisle

Back in North America, the company faces more cautious shoppers and the rise of modern GLP-1 weight-loss medications. Research published in the Journal of Marketing Research found that U.S. households cut snack spending by an average of 10% after starting such a treatment — a trend that has visibly tempered expectations for near-term volume growth in PepsiCo's home market.

Attention now centers on the upcoming earnings report, where reliable demand signals in the consumer business and strict cost discipline will be the key focal points. Even so, experts continue to assign the U.S. conglomerate a wide economic moat, underpinned by deeply rooted retail relationships and enormous scale in procurement and global distribution.

Portfolio Strategy in the Spotlight

How the product lineup is positioned matters greatly. The snack portfolio remains well placed to capture market share, yet the picture for refreshments stays demanding. In carbonated drinks, PepsiCo has so far been unable to narrow the gap to rival Coca-Cola. To spark growth beyond that core, management is increasingly weighing new private labels and licensing partnerships with third parties for non-carbonated beverages.

Dividend Record Offers a Cushion

For income-focused investors, the equity retains defensive appeal: the company has now raised its dividend for 54 consecutive years. With the shares sitting 21% below their 52-week high, the valuation already discounts a good deal of investor anxiety. Whether sentiment brightens on a lasting basis will depend above all on how demand and margin stability evolve from here.